Wow, what a brilliant analysis! Hmmm, let me toss out $500M here for this drug, oh maybe $800M for that drug, what about $400M for this other drug and surely the pipeline's a lock and should add billions to sales. And the mysterious meeting with a nameless insider surely must mean a Japanese buyout is just around the corner. Takeda? Astellas? Daiichi??